Clinical Trial Update: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

View source ↗

Summary

A completed NHLBI-sponsored clinical trial evaluating the transfer of GPI-linked proteins to transfused patients with paroxysmal nocturnal hemoglobinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Paroxysmal Hemoglobinuria | Status: COMPLETED